Skip to main content
logo
Sun Pharmaceutical Industries Limited (NSE:SUNPHARMA)
India flag India · Delayed Price · Currency is INR
1,840.00
-51.30 (-2.71%)
May 22, 2026, 3:30 PM IST

NSE:SUNPHARMA Revenue

In the fiscal year ending March 31, 2026, Sun Pharmaceutical Industries had annual revenue of 584.62B INR with 11.19% growth. Sun Pharmaceutical Industries had revenue of 146.12B in the quarter ending March 31, 2026, with 12.76% growth.

Revenue
584.62B
Revenue Growth
+11.19%
P/S Ratio
7.57
Revenue / Employee
13.60M
Employees
43,000
Market Cap
4.43T

Revenue Chart

Revenue History

Fiscal Year EndRevenueChangeGrowth
Mar 31, 2026584.62B58.84B11.19%
Mar 31, 2025525.78B40.82B8.42%
Mar 31, 2024484.97B46.11B10.51%
Mar 31, 2023438.86B52.31B13.53%
Mar 31, 2022386.54B51.56B15.39%
Mar 31, 2021 Pro Pro Pro
Mar 31, 2020 Pro Pro Pro
Mar 31, 2019 Pro Pro Pro
Mar 31, 2018 Pro Pro Pro
Mar 31, 2017 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company NameRevenue
Aurobindo Pharma336.53B
Cipla277.12B
Zydus Lifesciences271.48B
Glenmark Pharmaceuticals165.10B
Mankind Pharma142.78B
Alkem Laboratories142.53B
Divi's Laboratories103.14B
Ipca Laboratories95.06B
Revenue Rankings

Sun Pharmaceutical Industries News

More News